Saturday, July 21, 2018

Lynbrook pharmacy owner sentenced to jail for $1.5M Medicaid scam hours ago
The owner of a Lynbrook pharmacy was sentenced to jail time in Queens Supreme Court on Friday for defrauding the state's Medicaid program out of $1.5 ...

Oklahoma State Bureau of Investigation is looking into whether the director of the State Board of Pharmacy tried to bribe a health department attorney

OSBI Investigates State Board Of Pharmacy Director For Bribery KWTV-11 hours ago
The Oklahoma State Bureau of Investigation is looking into whether the director of the State Board of Pharmacy tried to bribe a health department attorney into ...

CVS fires Fountain Hills pharmacist who denied hormone prescription ... hours ago
She claims the pharmacist loudly questioned her in front of other customers and rejected her and her doctor's requests to transfer the prescription to another ...

CDER announces sweeping structural changes--The Division of Compounded Drugs will take on the roles of the Compounding and Pharmacy Practice Branch

CDER announces sweeping structural changes in letter from ...

BioPharma Dive-19 hours ago
The Division of Compounded Drugs will take on the roles of the Compounding and Pharmacy Practice Branch, and work alongside the Division of Unapproved ...

Former sales rep arrested on violations of pretrial release Hawaii News Now-15 hours ago According to the Department of Justice, Diaz was “prescribing medically unnecessary compounded medications, some of which included Ketamine, a controlled

Former sales rep arrested on violations of pretrial release

Hawaii News Now-15 hours ago
According to the Department of Justice, Diaz was “prescribing medically unnecessary compounded medications, some of which included Ketamine, a controlled 

Friday, July 20, 2018

Statement from FDA warning about significant health risks of contaminated illegal synthetic cannabinoid products that are being encountered by FDA Statement from Commissioner Scott Gottlieb, M.D.; Peter Marks, M.D., Ph.D., director, Center for Biologics Evaluation and Research; and Janet Woodcock, M.D., director, Center for Drug Evaluation and Research

The U.S. Food and Drug Administration has become aware of reports of severe illnesses and deaths resulting from the use of synthetic cannabinoid (marijuana) products that have been contaminated with brodifacoum, a very long-acting anticoagulant commonly used in rat poison. These unapproved products are being sold in convenience stores and gas stations as substitutes for marijuana under names such as “K2” and “Spice.” Use of these illegal products pose significant public health concerns for both individuals who may use the contaminated products and the U.S. blood supply, as there is the potential for contamination of blood products donated by those individuals who have used these substances.

New charges filed in New England Compounding Center case

New charges filed in New England Compounding Center case
Federal prosecutors have charged another person in the sprawling New England Compounding Center case, accusing a former pharmacy buyer at a ...

High Importance!! USP tackles 'hot mess' — veterinary compounding

USP tackles 'hot mess' — veterinary compounding
Timeline for U.S. Pharmacopeia recommendations on hazardous drugs and compounded preparations Veterinary compounding in the United States ..

FDA provides scientific and regulatory clarity for generic drug developers through the issuance of 43 new or revised product-specific guidance documents, including hard-to-copy complex generics and abuse-deterrent formulations of opioids

The U.S. Food and Drug Administration today announced a new batch of product-specific guidances to support industry in identifying appropriate science-based methodologies and evidence for developing generic drugs. The batch contains 43 product-specific guidances, including 26 new guidances and 17 revised guidances that, when finalized, will describe the FDA’s current thinking and expectations on how to develop generic drug products that are therapeutically equivalent to their respective reference-listed drugs.

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to encourage the development of and broaden access to generic versions of opioid analgesics that are formulated to deter abuse

One of the ways that the U.S. Food and Drug Administration is working to address the opioid epidemic is by encouraging the development of opioid analgesic products that are harder to manipulate and abuse. Opioids with abuse-deterrent formulations (ADFs) are intended to make certain types of abuse, such as crushing a tablet to snort or dissolving a capsule to inject, more difficult or less rewarding. 

These innovative formulations are designed to make it harder for people to manipulate the opioid product so they can’t be as easily abused to deliver an immediate “high.” But it’s important that prescribers and patients understand that these drugs are not “abuse-proof,” and they do not prevent addiction, overdose or death.

Statement from FDA Commissioner Scott Gottlieb, M.D., on manufacturer announcement to halt Essure sales in the U.S.; agency’s continued commitment to postmarket review of Essure and keeping women informed

The U.S. Food and Drug Administration was notified by Bayer that the Essure permanent birth control device will no longer be sold or distributed after December 31, 2018. This decision follows the FDA’s patient safety action in April, in which the agency issued an order restricting the sale and distribution of Essure; it was a unique type of restriction where the FDA used its authority to impose additional requirements to provide a reasonable assurance of the device’s safety and effectiveness.

The decision today to halt Essure sales also follows a series of earlier actions that the FDA took to address the reports of serious adverse events associated with its use.

State pharmacy board director allegedly offered job in exchange for controversial medical marijuana rule

State pharmacy board director allegedly offered job in exchange for controversial 

Wednesday, July 18, 2018

Brentwood Brothers Face Prison For Bogus Pharmacy Compounding Drug Pedaling

Brentwood Brothers Face Prison For Bogus Pharmacy Drug Pedaling minutes ago
Dalibor "Dabo" Kabov and his older brother Berry -- operators of Global CompoundingPharmacy -- were convicted in January 2017 of being at the center of a ..

CareZone sues Express Scripts for defamation following contract fight

FierceHealthcare-18 hours ago
A mounting battle between Express Scripts and online pharmacy CareZone just got a little more heated. Weeks after CareZone accused Express Scripts of ...

Amazon eyes India pharmacy space, to invest in pharmacy chain ...

Entrackr-Jul 16, 2018
US e-tailer major Amazon is in early talks to invest in India's second largest pharmacychain Medplus. Amazon, which considers India to be one of its key ...

Amazon's Reach Now Extends To Pharmacies

Global Finance-12 hours ago
Online marketplace Amazon disrupted the entire pharmacy industry—for a day at least—with its $1 billion purchase of PillPack, an online pharmacy that uses ...

Wedgewood Pharmacy and Diamondback Drugs Animal-Health ...

Arizona Daily Star-10 hours ago
As the top compounding pharmacy in the U.S., the new, combined company ... pharmacy to become the largest animal-health compounding pharmacy in the.
Doggone it: Wedgewood Pharmacy acquires Arizona competitor
Philadelphia Business Journal-8 hours ago
Allergan Awarded $27K In Sanctions In Compounding Suit

Law360 · 9 hours ago
07/03/2018AniCell BiotechLos Angeles District OfficeUnapproved New Animal Drug/AdulteredNot Issued *
07/03/2018bB BioChem Laboratories Inc.Los Angeles District OfficeCGMP/Finished Pharmaceuticals/Adulterated/Unapproved New DrugNot Issued *
07/05/2018Claris Injectables LimitedCenter for Drug Evaluation and ResearchCGMP/Finished Pharmaceuticals/AdulteratedNot Issued *
07/06/2018Aegle Nutrition LLCDallas District OfficeCGMP/Dietary Supplement/Adulterated/MisbrandedNot Issued *

Monday, July 16, 2018

Miracle Hills landlord wants to evict Kohll's Pharmacy over horse-drug conviction Jul 13, 2018

Posted: 16 Jul 2018 01:46 AM PDT
In 2010, the Federal Food, Drug, and Cosmetic Act (FDC Act) was amended to include a requirement that certain vending machine operators engaged in operating and owning 20 or more vending machines provide calorie declarations for certain articles of food sold from vending machines. FDA issued a final implementing regulation on Dec. 1, 2014 with a compliance date of Dec. 1, 2016.
Have you reviewed TSBP’s red flag checklist lately?
Failure of pharmacies and pharmacists to detect patterns of inappropriate dispensing of prescription drugs is unprofessional practice and constitutes grounds for disciplinary action. View our list of red flags here.

Friday, July 13, 2018

High importance!! FDA warns of imposters sending consumers fake warning letters Scammers are targeting consumers who have purchased medicines online

Scammers are targeting consumers who have purchased medicines online
The U.S. Food and Drug Administration is warning consumers about criminals forging FDA warning letters to target individuals who tried to purchase medicines online or over the phone. 

Based on the agency’s experience with criminals posing as FDA employees, the FDA is concerned that these fake warning letters are linked

FCA Alert: Medical judgment can be "false" under False Claims Act

JD Supra (press release)-7 hours ago
Two weeks ago, the Sixth Circuit reversed a judgment that had acquitted a cardiologist charged with criminal healthcare fraud stemming from his interpretations

Sessions targets 10 areas in US for crackdown on the sale of fentanyl

Washington Post-9 hours ago
CONCORD, N.H. — Attorney General Jeff Sessions on Thursday ordered federal prosecutors in 10 areas that have been especially hard-hit by overdose deaths ...

Attorney General: 'Fake' doctor bills $1M out of Denville office

Daily Record-7 hours ago
Marrero allegedly used the personal information of a Hudson County family physician to submit fraudulent insurance claims to United Healthcare Insurance Co.

Columbus doctor indicted in fraud investigation

WRBL-6 hours ago
COLUMBUS, GA - A Columbus doctor of 16 years has been indicted in a massive healthcare fraudinvestigation. The Ledger-Enquirer reports Dr. Alap Shah ..

Thursday, July 12, 2018

Doctor in Health Care Fraud Case Described as an Alligator-Wrestling ...

Deadline Detroit-17 hours ago
The feds have little good to say about Dr. Frank Patino, who is accused of orchestrating a $112 million health care fraud. In fact, Robert Snell of The Detr

Columbus doctor indicted in nation's largest health-care fraud ...

Columbus Ledger-Enquirer-13 hours ago
... and private insurance companies for medically unnecessary prescription drugs and compounded medications that often were never even purchased and/or

Physician Practice Roundup—Doctor played role in rescue from ...

FierceHealthcare-12 hours ago
A Houston doctor pleaded not guilty to federal charges Tuesday that he participated in a wide-ranging fraud scheme involving compounded drugs.

Nevada execution delayed indefinitely after ruling on drug

KOB-22 hours ago
Unlike Texas, which has carried out more executions than any other state, Nevada does not have a compounding pharmacy to get its drugs. Jordan T. Smith ..

Junior dos Santos laments impact of doping controversy on his career

Yahoo Entertainment-8 hours ago
It blamed the positive test for hydrochlorothiazide on contamination by a compounding pharmacy in Brazil. He was given a prescription by a Brazil doctor for a ...

Pharmacy Chain Takes Center Stage in Latest DOJ-OIG Takedown

Lexology-12 hours ago
Numerous compounding pharmacies, pharmacy owners, pharmacists, physicians, physician assistants, and nurses were indicted for their alleged participation .

Letco Medical, LLC Acquired by Current Management Team

Markets Insider-9 hours ago
Our talented and engaged team of associates, combined with our immense optimism about the future of compounding, make this the opportune time for the ...

FDA warns veterinarians against Ranier's Compounding Laboratory

dvm360-12 hours ago
In March 2017, the FDA issued a warning letter to Ranier's Compounding Laboratory after an inspection. During a recent follow-up inspection of the company's ..

FDA warns against using possible nonsterile animal drug products hours ago
FDA issued a warning letter to Ranier's Compounding in March 2017 following an inspection. During FDA's recent follow-up inspection of Ranier's compounding .

Minimizing Exposure to Hazardous Drugs in Compounding Pharmacy
14 hours ago - Developing new habits for hazardous drug handling aiming to keep employees safer and make environments cleaner is one of the purposes of USP 800. Therefore, a new iteration of comprehensive compounding records that defines the purpose more clearly is recommende